May 27, 2020 — U.S. District Judge Jane Triche Milazzo dismissed nearly 200 lawsuits by patients, saying the change in the drug’s warning label in 2015 clearly explained its risks. She ruled that the updated Taxotere label was legally adequate as it warned about the risk of the permanent hair loss patients suffered. Judge Milazzo explained that the label “clearly and consistently” explained the risk following the December 2015 change by including reports of permanent alopecia in the adverse reactions section and by advising doctors to inform patients of the side effect. Judge Milazzo also stated that the plaintiffs’ lawyers did not provide evidence that supported the risk of permanent alopecia needing to be included in a specific section of the label.
At this time, there were 12,690 Taxotere cases pending before Judge Milazzo in the MDL against drug manufacturers that included Sanofi.
Reference: Raymond, Nate. “Warning Label Change for Sanofi’s Taxotere Dooms 200 Hair Loss Cases – Judge.” Reuters, Thomson Reuters, 28 May 2020, www.reuters.com/article/products-taxotere/warning-label-change-for-sanofis-taxotere-dooms-200-hair-loss-cases-judge-idUSL1N2DA1ZO